R.J. Slappendel

1.1k total citations
34 papers, 835 citations indexed

About

R.J. Slappendel is a scholar working on Hematology, Epidemiology and Immunology. According to data from OpenAlex, R.J. Slappendel has authored 34 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in R.J. Slappendel's work include Blood groups and transfusion (12 papers), Platelet Disorders and Treatments (9 papers) and Research on Leishmaniasis Studies (6 papers). R.J. Slappendel is often cited by papers focused on Blood groups and transfusion (12 papers), Platelet Disorders and Treatments (9 papers) and Research on Leishmaniasis Studies (6 papers). R.J. Slappendel collaborates with scholars based in Netherlands, United States and Germany. R.J. Slappendel's co-authors include Erik Teske, F. van Knapen, Abdallah el Harith, E. Huigen, A H Kolk, A. Dekker, Christine J. Piek, Eefje J. A. Schrauwen, L.J. Hellebrekers and Chris T.W.M. Schneijdenberg and has published in prestigious journals such as Journal of Clinical Microbiology, European Journal of Clinical Investigation and Veterinary Record.

In The Last Decade

R.J. Slappendel

32 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.J. Slappendel Netherlands 15 426 292 273 166 105 34 835
Philippe Bossi France 18 190 0.4× 278 1.0× 136 0.5× 79 0.5× 45 0.4× 44 992
G.C. Troy United States 14 60 0.1× 192 0.7× 116 0.4× 114 0.7× 32 0.3× 20 655
Maria Teresa Antognoni Italy 17 80 0.2× 103 0.4× 113 0.4× 117 0.7× 71 0.7× 62 694
Sivakumar R. Rathinam India 27 270 0.6× 157 0.5× 42 0.2× 436 2.6× 108 1.0× 71 1.7k
P Woo United Kingdom 8 268 0.6× 473 1.6× 59 0.2× 182 1.1× 34 0.3× 18 688
M. Nishio Japan 14 87 0.2× 201 0.7× 86 0.3× 65 0.4× 18 0.2× 30 590
Earl H. Fife United States 12 162 0.4× 177 0.6× 54 0.2× 125 0.8× 35 0.3× 30 606
Maurice Longson United Kingdom 16 156 0.4× 493 1.7× 27 0.1× 197 1.2× 54 0.5× 47 985
Jussara Bianchi Castelli Brazil 16 74 0.2× 280 1.0× 45 0.2× 150 0.9× 34 0.3× 44 575
Marta Planellas Spain 13 259 0.6× 170 0.6× 30 0.1× 167 1.0× 14 0.1× 30 533

Countries citing papers authored by R.J. Slappendel

Since Specialization
Citations

This map shows the geographic impact of R.J. Slappendel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. Slappendel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. Slappendel more than expected).

Fields of papers citing papers by R.J. Slappendel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. Slappendel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. Slappendel. The network helps show where R.J. Slappendel may publish in the future.

Co-authorship network of co-authors of R.J. Slappendel

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. Slappendel. A scholar is included among the top collaborators of R.J. Slappendel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. Slappendel. R.J. Slappendel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piek, Christine J., et al.. (2008). Idiopathic Immune-Mediated Hemolytic Anemia: Treatment Outcome and Prognostic Factors in 149 Dogs. Journal of Veterinary Internal Medicine. 22(2). 366–373. 103 indexed citations
2.
Slappendel, R.J., et al.. (2005). Hereditary Spectrin Deficiency in Golden Retriever Dogs. Journal of Veterinary Internal Medicine. 19(2). 187–187. 17 indexed citations
3.
Slappendel, R.J., et al.. (2005). Hereditary Spectrin Deficiency in Golden Retriever Dogs. Journal of Veterinary Internal Medicine. 19(2). 187–192. 18 indexed citations
4.
Oost, Bernard A. van, Serge A. Versteeg, & R.J. Slappendel. (2004). DNA Testing for Type III von Willebrand Disease in Dutch Kooiker Dogs. Journal of Veterinary Internal Medicine. 18(3). 282–282. 6 indexed citations
5.
Oost, Bernard A. van, Serge A. Versteeg, & R.J. Slappendel. (2004). DNA Testing for Type III von Willebrand Disease in Dutch Kooiker Dogs. Journal of Veterinary Internal Medicine. 18(3). 282–288. 9 indexed citations
6.
Versteeg, Serge A., Robin E. Everts, R.J. Slappendel, & Bernard A. van Oost. (2000). Genetic and physical ordering of polymorphic DNA markers in the region of the canine von Willebrand factor gene. Animal Genetics. 31(6). 414–415. 3 indexed citations
7.
Pinelli, Elena, et al.. (1999). Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction. Veterinary Immunology and Immunopathology. 69(2-4). 121–126. 48 indexed citations
8.
Slappendel, R.J.. (1998). Congenital [Hereditary] Clotting Disorders in the Dog. Veterinary Quarterly. 20(sup1). S41–S43. 2 indexed citations
9.
Slappendel, R.J., et al.. (1998). DNA Analysis in Diagnosis of Von Willebrand Disease in Dogs. Veterinary Quarterly. 20(sup1). S90–S91. 5 indexed citations
10.
Slappendel, R.J.. (1998). Abnormal Osmotic Fragility of Erythrocytes in Dogs and Cats. Veterinary Quarterly. 20(sup1). S38–S39. 7 indexed citations
11.
12.
Slappendel, R.J., et al.. (1997). A case of autochthonous canine leishmaniasis in the Netherlands. Veterinary Quarterly. 19(2). 69–71. 31 indexed citations
13.
Renooij, Willem, et al.. (1996). Gastric mucosal phospholipids in dogs with familial stomatocytosis−hypertrophic gastritis. European Journal of Clinical Investigation. 26(12). 1156–1159. 1 indexed citations
14.
Meyer, H.P., et al.. (1993). Polycythaemia vera in a dog treated by repeated phlebotomies. Veterinary Quarterly. 15(3). 108–111. 8 indexed citations
15.
Slappendel, R.J., et al.. (1992). An enzyme-linked immunosorbent assay (ELISA) for von Willebrand factor antigen (vWf-Ag) in canine plasma. Veterinary Immunology and Immunopathology. 33(1-2). 145–154. 12 indexed citations
16.
Slappendel, R.J., et al.. (1991). Familial stomatocytosis — hypertrophic gastritis (FSHG), a newly recognised disease in the dog (Drentse patrijshond). Veterinary Quarterly. 13(1). 30–40. 19 indexed citations
17.
Slappendel, R.J.. (1988). Disseminated Intravascular Coagulation. Veterinary Clinics of North America Small Animal Practice. 18(1). 169–184. 40 indexed citations
18.
Slappendel, R.J., et al.. (1987). Transient juvenile hypoglycaemia in a Yorkshire terrier and in a Chihuahua. Veterinary Quarterly. 9(2). 172–176. 4 indexed citations
19.
Hellebrekers, L.J., R.J. Slappendel, & W. E. van den Brom. (1985). Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. American Journal of Veterinary Research. 46(7). 1460–1462. 18 indexed citations
20.
Slappendel, R.J.. (1979). The diagnostic significance of the direct antiglobulin test (DAT) in anemic dogs. Veterinary Immunology and Immunopathology. 1(1). 49–59. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026